The Shotlee Journal
Browse Shotlee articles about Weight Management.
Showing 9 / 869 Weight Management articles
Recent research suggests that GLP-1 medications like Ozempic, typically used for diabetes and weight management, might also positively impact brain health. The study indicates a lower risk of epilepsy development in individuals with Type 2 diabetes using these drugs.
Instead of prescriptions, discover how to boost your body's natural 'Ozempic' by leveraging nutrition and lifestyle. By eating the right foods, you can increase GLP-1, a hormone that controls cravings and supports metabolism.
The Delhi High Court has upheld a previous ruling that allows Dr. Reddy's Laboratories to manufacture Semaglutide for export. This decision comes amid an ongoing patent dispute with Novo Nordisk, who claims Dr. Reddy's infringed on their Semaglutide patent.
The weight loss drug Ozempic has been introduced in India by Novo Nordisk, with a weekly cost of $24.35 for 0.25mg doses. This move occurs amidst increasing global demand for weight management solutions. India represents a significant market due to its high rates of type 2 diabetes and obesity.
A new weight loss drug, retatrutide, is showing promise by mimicking three hunger-regulating hormones. Clinical trial data indicates significant weight loss and reduced knee pain.
A novel drug candidate from Eli Lilly, targeting three metabolic pathways, has shown impressive weight loss results in a late-stage clinical trial. The study revealed an average weight loss of 28.7% among participants. However, the trial also reported a notable rate of treatment discontinuation.
As the holiday season approaches, many individuals express concerns regarding potential weight gain. Prestige Men's Health in Holladay is offering medically supervised weight-loss programs using GLP-1 treatments like semaglutide, providing screening, labs, and continuous monitoring. This comes as more Utah residents seek medical guidance for weight management during this time.
Cipla has released Yurpeak (tirzepatide), a weekly injectable medication designed for adults managing obesity and type 2 diabetes. As the second tirzepatide brand from Lilly available in India, Yurpeak will be accessible through prescription in a user-friendly KwikPen.
An ITV presenter, known for her financial expertise on Lorraine, has publicly discussed her weight loss journey. She attributes her four-stone weight loss to the use of Mounjaro, resulting in a significant change in her dress size.
